Our hosting provider will be performing UPS maintenance on Tuesday, Oct 25, 2016 between 8 AM and 5 PM PDT. SciCrunch searching services will be down during this time.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Serum leptin level is a regulator of bone mass.


Leptin is a powerful inhibitor of bone formation in vivo. This antiosteogenic function involves leptin binding to its receptors on ventromedial hypothalamic neurons, the autonomous nervous system and beta-adrenergic receptors on osteoblasts. However, the mechanisms whereby leptin controls the function of ventromedial hypothalamic antiosteogenic neurons remain unclear. In this study, we compared the ability of leptin to regulate body weight and bone mass and show that leptin antiosteogenic and anorexigenic functions are affected by similar amounts of leptin. Using a knock-in of LacZ in the leptin locus, we failed to detect any leptin synthesis in the central nervous system. However, increasing serum leptin level, even dramatically, reduced bone mass. Conversely, reducing serum-free leptin level by overexpressing a soluble receptor for leptin increased bone mass. Congruent with these results, the high bone mass of lipodystrophic mice could be corrected by restoring serum leptin level, suggesting that leptin is an adipocyte product both necessary and sufficient to control bone mass. Consistent with the high bone mass phenotype of lipodystrophic mice, we observed an advanced bone age, an indirect reflection of premature bone formation, in lipodystrophic patients. Taken together, these results indicate that adipocyte-derived circulating leptin is a determinant of bone formation and suggests that leptin antiosteogenic function is conserved in vertebrates.

Pubmed ID: 14978271


  • Elefteriou F
  • Takeda S
  • Ebihara K
  • Magre J
  • Patano N
  • Kim CA
  • Ogawa Y
  • Liu X
  • Ware SM
  • Craigen WJ
  • Robert JJ
  • Vinson C
  • Nakao K
  • Capeau J
  • Karsenty G


Proceedings of the National Academy of Sciences of the United States of America

Publication Data

March 2, 2004

Associated Grants

  • Agency: NIDDK NIH HHS, Id: DK 5883

Mesh Terms

  • Animals
  • Bone Density
  • Brain
  • Cerebral Ventricles
  • Homeostasis
  • Humans
  • Infusions, Parenteral
  • Leptin
  • Lipodystrophy
  • Mice
  • Mice, Obese
  • Mice, Transgenic